south congress semaglutide weight loss Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain efficacy Weight loss results after 8

Medicare covers GLP-1s for $50/month starting July 2026 For decades, a legal exclusion blocked Medicare from covering drugs used for anorexia, weight loss, or weight gain. That sentence is the reason a Medicare beneficiary with a BMI of 38 could not get Wegovy through their drug plan (unless they also had established cardiovascular disease)

Press release: Safety, pharmacokinetics, and pharmacodynamics of CT-996, an oral small-molecule, signal-biased GLP-1 receptor agonist over 4 weeks in adults with obesity

In developing countries, because of the prevalence of iodine and vitamin A co-deficiency, the risk of thyroid disorders, particularly in children, has been of interest

Some concerns persist regarding the safety of semaglutide

If accuracy at low doses is a concern, some prescribers deliberately start patients on the 8mg/mL vial for the first four to eight weeks, then switch to 17mg/mL for higher doses